Your browser doesn't support javascript.
loading
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.
Gregersen, Henrik; Do, Trung; Kristensen, Ida Bruun; Frølund, Ulf Christian; Andersen, Niels Frost; Nielsen, Lene Kongsgaard; Andersen, Christen Lykkegaard; Klausen, Tobias Wirenfeldt; Vangsted, Annette Juul; Abildgaard, Niels.
Afiliação
  • Gregersen H; 1Department of Hematology, Aalborg University Hospital, Mølleparkvej 4, 9000 Aalborg, Denmark.
  • Do T; 2Department of Hematology, Herlev Hospital, 2730 Herlev, Denmark.
  • Kristensen IB; 3Department of Hematology, Vejle Hospital, 7100 Vejle, Denmark.
  • Frølund UC; 4Department of Hematology, Zealand University Hospital, 4000 Roskilde, Denmark.
  • Andersen NF; 5Department of Hematology, Aarhus University Hospital, 8000 Aarhus, Denmark.
  • Nielsen LK; 6Quality of Life Research Center OUH, Odense University Hospital, 5000 Odense C, Denmark.
  • Andersen CL; 4Department of Hematology, Zealand University Hospital, 4000 Roskilde, Denmark.
  • Klausen TW; 2Department of Hematology, Herlev Hospital, 2730 Herlev, Denmark.
  • Vangsted AJ; 7Department of Hematology, Rigshospitalet, 2100 Copenhagen, Denmark.
  • Abildgaard N; 8Department of Hematology, Odense University Hospital, 5000 Odense C, Denmark.
Exp Hematol Oncol ; 7: 18, 2018.
Article em En | MEDLINE | ID: mdl-30123673

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2018 Tipo de documento: Article